Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
RaySearch Laboratories AB's quarterly market cap
declined
from Sep. 2025 (kr8,639 Mil) to Dec. 2025 (kr7,817 Mil) and
declined
from Dec. 2025 (kr7,817 Mil) to Mar. 2026 (kr6,562 Mil).
RaySearch Laboratories AB's annual market cap
increased
from Dec. 2023 (kr3,096 Mil) to Dec. 2024 (kr7,405 Mil) and
increased
from Dec. 2024 (kr7,405 Mil) to Dec. 2025 (kr7,817 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. RaySearch Laboratories AB's Enterprise Value for Today is kr5,969 Mil.
RaySearch Laboratories AB (OSTO:RAY B) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
RaySearch Laboratories AB Market Cap Related Terms
RaySearch Laboratories AB Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:RAY B vs VEEV, BTSG, TEM: Market Cap Comparison
For the Health Information Services subindustry, RaySearch Laboratories AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
RaySearch Laboratories AB Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, RaySearch Laboratories AB's Market Cap distribution charts can be found below:
* The bar in red indicates where RaySearch Laboratories AB's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RaySearch Laboratories AB (OSTO:RAY B) has a Market Cap of kr6,031 Mil as of Jul. 21, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on RaySearch Laboratories AB and its competitors. According to the industry distribution chart, RaySearch Laboratories AB ranks #178 out of 695 companies in the Healthcare Providers & Services industry, placing it in the top 25.6%.
Is RaySearch Laboratories AB's Market Cap too high?
RaySearch Laboratories AB's current Market Cap is kr6,031 Mil. Based on the distribution chart, RaySearch Laboratories AB ranks #178 out of 695 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, RaySearch Laboratories AB has a GF Score™ of 91/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does RaySearch Laboratories AB's Market Cap compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, RaySearch Laboratories AB ranks #178 out of 695 companies for Market Cap. This puts RaySearch Laboratories AB in the upper half of its industry. The industry median Market Cap is 103.63. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 103.63, based on 695 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on RaySearch Laboratories AB and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 103.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. RaySearch Laboratories AB's current Market Cap is kr6,031 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RaySearch Laboratories AB stock overvalued right now?
Based on GuruFocus' analysis, RaySearch Laboratories AB (OSTO:RAY B) is currently considered Fairly Valued. The stock's GF Value™ is kr193.00, compared to a current price of kr177.90 — trading 7.8% below its estimated fair value. The current Market Cap is kr6,031 Mil. RaySearch Laboratories AB's overall GF Score™ is 91/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For RaySearch Laboratories AB (OSTO:RAY B), the current Market Cap is kr6,031 Mil as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is RaySearch Laboratories AB (OSTO:RAY B) Overvalued in 2026?
Based on GuruFocus' analysis, RaySearch Laboratories AB stock appears to be undervalued.
The current stock price of kr177.90 is trading 7.8% below its estimated GF Value™ of kr193.00.
GuruFocus considers RaySearch Laboratories AB to be Fairly Valued.
Key valuation signals for OSTO:RAY B:
Market Cap: kr6,031 Mil
GF Value™: kr193.00 vs. price of kr177.90 (7.8% below fair value)
No single metric tells the full story. See the OSTO:RAY B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
RaySearch Laboratories AB is a Sweden-based medical technology company. The company develops software solutions for improved cancer treatment. The company develops and markets the RayStation treatment planning system and RayCare oncology information system to clinics all over the world and distributes products through licensing agreements with medical technology companies. Its geographic segments consist of the Americas, Asia-Pacific & Middle East, Europe, and the rest of world.
91GF Score
Get the complete analysis for OSTO:RAY B
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:RAY B has been successfully added to your 
